Value Microcaps Motherboard

[Rawnoc]

BIOYF / RX.V is a potential multi-bagger home run IMO. Here's why:

(1) BIOYF / RX.V is debt-free, cash-rich making money hand over fist compared to its tiny market cap and growing rapidly. Their key product, Feramax, is getting rave reviews by pharmacists, doctors, and users.

http://www.babycenter.ca/thread/26739/low-iron-anyone
http://www.crohnsforum.com/showthread.php?t=27666
http://www.healthboards.com/boards/4698267-post5.html
http://ivf.ca/forums/topic/20978-feramax-iron-supplements
http://forums.weddingbells.ca/ubbthreads.php?ubb=showflat&Number=3630907
http://www.healthboards.com/boards/anemia/858534-how-much-iron-too-much.html

(2) Last quarter they had +.025 EPS (w/o one-timers of .006). Annualized + growth makes them appear very cheap to me especially vs. future increased potential EPS.

(3) Their pharmaceutical sales division has shown on average +40% sequential growth in sales each quarter for many quaters so far. Over +215% year-over-year growth last quarter with massive gross profitability margins (78.6% company-wide last quarter)

(4) BIOYF / RX.V is expecting to launch 2 new products this year, and 4 more next year.

(5) The CFO has bought shares in the open market several times:
http://canadianinsider.com/node/7?menu_tickersearch=rx.v (that's the last 6 months alone)